FDA Inspection 1222037 — Kevin P. O'Brien, MD
The FDA completed an inspection of Kevin P. O'Brien, MD on September 20, 2023 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 20, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Denver, CO (United States)
Additional Details
Clinical Investigator (CI)